Corentec Co

Corentec Co Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Corentec Co (104540.KQ) as of Oct 17, 2026 is 0.20. In the previous year, Net Debt to Free Cash Flow Ratio was -0.70 — a change of -128.19% (higher).

Net Debt/FCF

0.20

YoY

-128.19%

Last updated:

Net Debt to Free Cash Flow Ratio of Corentec Co is 2025 0.20 . Net Debt to Free Cash Flow Ratio of Corentec Co was 2024 -0.70 . It decreases by -128.19% higher compared to the previous year.

The Corentec Co Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
12.34 KRW
Jan 1, 2019
14.42 KRW
Jan 1, 2020
-1.25 KRW
Jan 1, 2021
-0.11 KRW
Jan 1, 2022
-1.62 KRW
Jan 1, 2023
0.51 KRW
Jan 1, 2024
-0.70 KRW
Jan 1, 2025
0.20 KRW
The Corentec Co Net Debt/FCF history
YEARNet Debt/FCFYoY
0.20-128.19%
-0.70-237.20%
0.51-131.46%
-1.62+1,413.64%
-0.11-91.44%
-1.25-108.68%
14.42+16.90%
12.34-1,192.40%
-1.13-253.48%
0.74-135.82%
-2.05-27.59%
-2.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Net Debt to Free Cash Flow Ratio of Corentec Co is 0.20 in 2025.

Net Debt to Free Cash Flow Ratio of Corentec Co changed from -0.70 to 0.20, representing a -128.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Corentec Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Corentec Co

All Key Metrics — Corentec Co